Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled.

Nature and Science of Sleep
Junlong GuoBin Zhang

Abstract

The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had been initially control. An online survey was conducted among Chinese citizens through the JD Health APP. The questionnaire was used for collecting demographic data and self-designed questions related to the COVID-19 outbreak. Insomnia Severity Index, Patient Health Questionnaire-9, Somatic Symptom Scale-8 and Impact of Events Scale-Revised were used for measuring psychological symptoms. To examine the associations of sociodemographic and psychological factors with insomnia symptoms, a binary logistic regression was used. In total, there were 14,894 eligible participants, and 4601 (30.9%) participants were found to have insomnia symptoms. The regression model revealed that a higher risk of insomnia symptoms was associated with being over the age of 40 years, having history of psychiatric disorders, smoking, having infected friends or colleagues, having depressive or somatic symptoms, experiencing psychological distress and feeling estranged from fa...Continue Reading

References

Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
May 25, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·William S GriesarBarry S Oken
Jul 20, 2002·Journal of Psychosomatic Research·Robert E RobertsIrene Ger Chen
Dec 17, 2002·Journal of Psychiatric Research·Maurice M Ohayon, Thomas Roth
Feb 4, 2003·Social Psychiatry and Psychiatric Epidemiology·K K Wu, K S Chan
Mar 26, 2003·Psychosomatic Medicine·Charles M MorinHans Ivers
Nov 28, 2013·JAMA Internal Medicine·Benjamin GierkBernd Löwe
Nov 12, 2014·Psychiatry and Clinical Neurosciences·Gulcin BenbirDerya Karadeniz
Feb 22, 2017·Sleep Medicine·Li-Jung ChenChing-Heng Lin
Jun 2, 2018·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Dhaval PatelPragnesh Patel
Jan 28, 2020·Lancet·Chen WangGeorge F Gao
Apr 1, 2020·International Journal of Biological Sciences·Wen LiYu-Tao Xiang
May 8, 2020·The American Journal of Psychiatry·Junying ZhouXiangdong Tang
Nov 3, 2020·Frontiers in Psychiatry·Xiaoqin ZengYongfu Zhang

❮ Previous
Next ❯

Software Mentioned

JD Health APP
SPSS Analytics

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.